# King Edward Medical University and Mayo Hospital, Lahore

Source: https://onco.cc/institutions/kemu-lahore/  
OnCo record `kemu-lahore` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A medical university in Lahore whose teaching hospital, Mayo Hospital, has a radiotherapy and oncology department that runs academic trials such as a gentler schedule of salvage chemotherapy for lymphoma.

## Summary

King Edward Medical University is a medical university in Lahore; its website lists a Radiotherapy and Oncology department among its clinical units. Its teaching hospital is Mayo Hospital. The university sponsors NCT07739654, a randomised phase 3 trial at Mayo Hospital, led by Abbas Khokhar, Professor of Medical Oncology and Radiotherapy, comparing a modified DHAP schedule (cisplatin 50 mg/m2 over six hours on days 1 and 2, cytarabine 2 g/m2 on days 1 and 2) with the standard schedule in 74 adults with relapsed or refractory diffuse large B-cell lymphoma, with overall response rate as the primary endpoint and the aim of reducing kidney toxicity and allowing outpatient treatment. The map position is the city centre.

## Fields

- Kind: Institution
- Last checked: 2026-11-04
- Also known as: KEMU; King Edward Medical University; Mayo Hospital Lahore
- City: Lahore, PK
- Type: university
- Website: https://kemu.edu.pk/

## Sources

- King Edward Medical University: https://kemu.edu.pk/
- ClinicalTrials.gov NCT07739654: https://clinicaltrials.gov/study/NCT07739654

## Connected records

- cancers: [Diffuse large B-cell lymphoma](https://onco.cc/cancers/dlbcl/)
- trials: [Modified against standard DHAP salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma (Lahore)](https://onco.cc/trials/nct07739654/)

---
JSON: https://onco.cc/api/v1/entities/kemu-lahore.json